Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Journal of Clinical Pharmacology
|
March 20, 1998
Olanzapine: interaction study with imipramine
J T Callaghan, B J Cerimele, K J Kassahun, et al.
British Journal of Clinical Pharmacology
|
October 1, 1996
Inhibition of ex vivo neutrophil activation by oral LY293111, a novel leukotriene B4 receptor antagonist
P Marder, S M Spaethe, L L Froelich, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1993
Effects of renal dysfunction on the pharmacokinetics of loracarbef
D G Therasse, D S Farlow, R L Davidson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine
B J Ring, J Catlow, T J Lindsay, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Journal of Clinical Pharmacology
|
March 20, 1998
Olanzapine: interaction study with imipramine
J T Callaghan, B J Cerimele, K J Kassahun, et al.
British Journal of Clinical Pharmacology
|
October 1, 1996
Inhibition of ex vivo neutrophil activation by oral LY293111, a novel leukotriene B4 receptor antagonist
P Marder, S M Spaethe, L L Froelich, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1993
Effects of renal dysfunction on the pharmacokinetics of loracarbef
D G Therasse, D S Farlow, R L Davidson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine
B J Ring, J Catlow, T J Lindsay, et al.
Page
of 3